Furthermore, PCa patients with higher FcγRIIIa mRNA expression in their tumors had worse biochemical recurrence (BCR)‐free survival compared to those with lower FcγRIIIa expression. The gene discussed is FCGR3A; the disease is posterior cortical atrophy.